Gene · 7296
Papers4,270
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 4,270
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Sex- and APOE-specific genetic risk factors for late-onset Alzheimer's disease: Evidence from gene-gene interaction of longevity-related loci. | Aging Cell | 2023 | 37621137 | PubTator, text mining | PubMed |
| GADD45B regulates the carcinogenesis process of chronic atrophic gastritis and the metabolic pathways of gastric cancer. | Front Endocrinol (Lausanne) | 2023 | 37608794 | PubTator, text mining | PubMed |
| Integration of phytotherapy and chemotherapy: Recent advances in anticancer molecular pathways. | Iran J Basic Med Sci | 2023 | 37605725 | PubTator, text mining | PubMed |
| Mechanisms and applications of radiation-induced oxidative stress in regulating cancer immunotherapy. | Front Immunol | 2023 | 37600785 | PubTator, text mining | PubMed |
| Ferroptosis: new insight into the mechanisms of diabetic nephropathy and retinopathy. | Front Endocrinol (Lausanne) | 2023 | 37600716 | PubTator, text mining | PubMed |
| High-Throughput Screening and Proteomic Characterization of Compounds Targeting Myeloid-Derived Suppressor Cells. | Mol Cell Proteomics | 2023 | 37586548 | PubTator, text mining | PubMed |
| Boosting NAD preferentially blunts Th17 inflammation via arginine biosynthesis and redox control in healthy and psoriasis subjects. | Cell Rep Med | 2023 | 37586364 | PubTator, text mining | PubMed |
| Bioinformatics analysis of the immune cell infiltration characteristics and correlation with crucial diagnostic markers in pulmonary arterial hypertension. | BMC Pulm Med | 2023 | 37582718 | PubTator, text mining | PubMed |
| Membrane Integrity Assay in Ferroptosis. | Methods Mol Biol | 2023 | 37578697 | PubTator, text mining | PubMed |
| Non-alcoholic fatty liver disease and diabetes mellitus as growing aetiologies of hepatocellular carcinoma. | JHEP Rep | 2023 | 37575883 | PubTator, text mining | PubMed |
| The NRF2-p97-NRF2 negative feedback loop. | Redox Biol | 2023 | 37573837 | PubTator, text mining | PubMed |
| The Anticancer Effect of Napabucasin (BBI608), a Natural Naphthoquinone. | Molecules | 2023 | 37570646 | PubTator, text mining | PubMed |
| Multifaceted role of redox pattern in the tumor immune microenvironment regarding autophagy and apoptosis. | Mol Cancer | 2023 | 37563639 | PubTator, text mining | PubMed |
| Auranofin targets UBA1 and enhances UBA1 activity by facilitating ubiquitin trans-thioesterification to E2 ubiquitin-conjugating enzymes. | Nat Commun | 2023 | 37558718 | PubTator, text mining | PubMed |
| Particulate matter impairs immune system function by up-regulating inflammatory pathways and decreasing pathogen response gene expression. | Sci Rep | 2023 | 37550362 | PubTator, text mining | PubMed |
| Role of ferroptosis in esophageal cancer and corresponding immunotherapy. | World J Gastrointest Oncol | 2023 | 37546564 | PubTator, text mining | PubMed |
| Interaction mechanisms between autophagy and ferroptosis: Potential role in colorectal cancer. | World J Gastrointest Oncol | 2023 | 37546557 | PubTator, text mining | PubMed |
| TAZ upregulates MIR-224 to inhibit oxidative stress response in multiple myeloma. | Cancer Rep (Hoboken) | 2023 | 37539777 | PubTator, text mining | PubMed |
| Antioxidant Defense Capacity Is Reduced in Thyroid Stem/Precursor Cells Compared to Differentiated Thyrocytes. | Int J Mol Sci | 2023 | 37511265 | PubTator, text mining | PubMed |
| The Development of p53-Targeted Therapies for Human Cancers. | Cancers (Basel) | 2023 | 37509223 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7296/papers?page=27